We performed this meta-analysis of randomized double-blind placebo-controlled clinical trials to evaluate the efficacy and safety of prophylactic antidepressants to prevent PEG-IFN-α/RBV-associated depression in patients with CHC. Here, IFNA1 is linked to major depressive disorder.